Skandinaviska Enskilda Banken Ab (Publ) Incyte Corp Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$21.5 Billion
Q3 2024

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Incyte Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 43,730 shares of INCY stock, worth $3.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

43,730

Previous 204,910 78.66%

Holding current value

$3.04 Million

Previous $12.4 Million 76.73%

% of portfolio

0.01%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$57.33 - $68.61 $9.24 Million - $11.1 Million	-161,180 Reduced 78.66%	43,730 $2.89 Million
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $700,449 - $872,482	13,686 Added 7.16%	204,910 $12.4 Million
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $5.97 Million - $7.03 Million	-105,638 Reduced 35.58%	191,224 $10.9 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $1.25 Million - $1.54 Million	23,923 Added 8.76%	296,862 $18.6 Million
Q3 2023 Nov 09, 2023	SELL	$57.77 - $65.93 $9.56 Million - $10.9 Million	-165,443 Reduced 37.74%	272,939 $15.8 Million
Q2 2023 Aug 07, 2023	BUY	$60.95 - $75.51 $1.45 Million - $1.79 Million	23,746 Added 5.73%	438,382 $27.3 Million
Q1 2023 May 11, 2023	BUY	$70.23 - $86.01 $8.69 Million - $10.6 Million	123,736 Added 42.54%	414,636 $30 Million
Q4 2022 Feb 08, 2023	SELL	$67.18 - $84.11 $3.17 Million - $3.97 Million	-47,193 Reduced 13.96%	290,900 $23.4 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $3.74 Million - $4.68 Million	-56,471 Reduced 14.31%	338,093 $22.5 Million
Q2 2022 Aug 10, 2022	BUY	$66.18 - $83.18 $3.12 Million - $3.92 Million	47,076 Added 13.55%	394,564 $30 Million
Q1 2022 May 11, 2022	BUY	$66.02 - $79.71 $9.58 Million - $11.6 Million	145,084 Added 71.68%	347,488 $27.6 Million
Q4 2021 Feb 10, 2022	SELL	$63.34 - $74.11 $635,553 - $743,619	-10,034 Reduced 4.72%	202,404 $15 Million
Q3 2021 Nov 10, 2021	BUY	$68.67 - $84.02 $8.29 Million - $10.1 Million	120,794 Added 131.81%	212,438 $14.6 Million
Q2 2021 Aug 10, 2021	SELL	$79.87 - $87.53 $801,495 - $878,363	-10,035 Reduced 9.87%	91,644 $7.71 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $1.11 Million - $1.46 Million	-14,571 Reduced 12.53%	101,679 $8.26 Million
Q4 2020 Feb 11, 2021	SELL	$80.74 - $97.7 $57,890 - $70,050	-717 Reduced 0.61%	116,250 $10.1 Million
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $881,665 - $1.14 Million	10,364 Added 9.72%	116,967 $10.5 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $225,284 - $330,820	3,037 Added 2.93%	106,603 $11.1 Million
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $999,886 - $1.36 Million	-15,826 Reduced 13.26%	103,566 $7.58 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $72,017 - $94,379	-986 Reduced 0.82%	119,392 $10.4 Million
Q3 2019 Nov 08, 2019	SELL	$72.82 - $86.52 $509,739 - $605,640	-7,000 Reduced 5.5%	120,378 $8.94 Million
Q2 2019 Aug 09, 2019	SELL	$73.52 - $88.7 $1.08 Million - $1.31 Million	-14,756 Reduced 10.38%	127,378 $10.8 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $267,905 - $371,636	-4,215 Reduced 2.88%	142,134 $12.2 Million
Q4 2018 Feb 12, 2019	BUY	$58.5 - $69.94 $307,710 - $367,884	5,260 Added 3.73%	146,349 $9.31 Million
Q3 2018 Nov 05, 2018	BUY	$61.75 - $74.23 $728,650 - $875,914	11,800 Added 9.13%	141,089 $9.75 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $4.36 Million - $6.02 Million	71,722 Added 124.59%	129,289 $8.66 Million
Q1 2018 Apr 30, 2018	SELL	$83.06 - $100.98 $609,577 - $741,092	-7,339 Reduced 11.31%	57,567 $4.8 Million
Q4 2017 Feb 12, 2018	SELL	$93.56 - $116.6 $809,948 - $1.01 Million	-8,657 Reduced 11.77%	64,906 $6.15 Million
Q3 2017 Nov 13, 2017	SELL	$109.15 - $138.27 $54,575 - $69,135	-500 Reduced 0.68%	73,563 $8.59 Million
Q2 2017 Aug 14, 2017	BUY	N/A	74,063	74,063 $0

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Incyte Corp Transaction History